Page last updated: 2024-11-08

reynosin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

reynosin: sesquiterpene derivative of costunolide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

reynosin : A sesquiterpene lactone of the eudesmanolide group, found particularly in Magnolia grandiflora and Laurus nobilis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
LaurusgenusA plant genus in the LAURACEAE family. Laurus nobilis L. leaves are known for use in SPICES, having a similar flavor as UMBELLULARIA.[MeSH]LauraceaeA family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.[MeSH]
MagnoliagenusA plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.[MeSH]MagnoliaceaeA plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals (sepals and petals that are not distinctly different) and many spirally arranged stamens.[MeSH]
Magnolia grandifloraspecies[no description available]MagnoliaceaeA plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals (sepals and petals that are not distinctly different) and many spirally arranged stamens.[MeSH]

Cross-References

ID SourceID
PubMed CID482788
CHEMBL ID272178
CHEBI ID540787
SCHEMBL ID1683362
MeSH IDM0066908

Synonyms (30)

Synonym
(3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-3,9-dimethylene-3a,4,5,6,7,8,9a,9b-octahydrobenzo[g]benzofuran-2-one
naphthol[1,2-b]furan-2(3h)-one,decahydro-6-hydroxy-5a-methyl-3,9-bis(methylene)-,[3as-(3aalpha,5abeta,6beta,9aalpha,9bbeta)]
28254-53-7
reynosin
nsc-155623
(3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-3,9-dimethylidene-3a,4,5,6,7,8,9a,9b-octahydrobenzo[g][1]benzofuran-2-one
CHEMBL272178
(+)-reynosin
(3as)-3a,4,5,5a,6,7,8,9,9abeta,9balpha-decahydro-6alpha-hydroxy-5aalpha-methyl-3,9-bis(methylene)naphtho[1,2-b]furan-2(3h)-one
chebi:540787 ,
(3as,9abeta,9balpha)-3a,4,5,5a,6,7,8,9,9a,9b-decahydro-6alpha-hydroxy-5aalpha-methyl-3,9-bis(methylene)naphtho[1,2-b]furan-2(3h)-one
(3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-3,9-bis(methylene)decahydronaphtho[1,2-b]furan-2(3h)-one
n26569l9v4 ,
nsc 155623
unii-n26569l9v4
naphtho(1,2-b)furan-2(3h)-one, decahydro-6-hydroxy-5a-methyl-3,9-bis(methylene)-, (3as-(3aalpha,5abeta,6beta,9aalpha,9bbeta))-
naphtho(1,2-b)furan-2(3h)-one, decahydro-6-hydroxy-5a-methyl-3,9-bis(methylene)-, (3as-(3a.alpha.,5a.beta.,6.beta.,9a.alpha.,9b.beta.))-
naphtho(1,2-b)furan-2(3h)-one, decahydro-6-hydroxy-5a-methyl-3,9-bis(methylene)-, (3as,5ar,6r,9as,9bs)-
reynosin, (+)-
eudesma-4(14),11(13)-dien-12-oic acid, 1.beta.,6.alpha.-dihydroxy-, .gamma.-lactone
reinosin
SCHEMBL1683362
NCGC00385273-01
AKOS032948484
(3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-3,9-dimethylenedecahydronaphtho[1,2-b]furan-2(3h)-one
FS-9710
Q27105167
(+)-reynosin; nsc 155623; reinosin
(3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-3,9-dimethylenedecahydronaphtho[1,2-b]furan-2(9bh)-one
(3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-3,9-dimethylidene-dodecahydronaphtho[1,2-b]furan-2-one

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Reynosin treatment significantly inhibited TAA-induced apoptosis and hepatocellular DNA damage in primary rat hepatocytes."( Hepatoprotective effects of reynosin against thioacetamide-induced apoptosis in primary hepatocytes and mouse liver.
Kim, KH; Lee, SJ; Lim, S; Mar, W; Nam, KW, 2013
)
1.41

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
sesquiterpene lactoneAny member of a diverse class of complex, multicyclic phytochemicals showing a variety of skeleton arrangements and bioactivities, and having in common a sesquiterpenoid structure including a lactone ring.
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID356400Antibacterial activity against vancomycin-resistant Enterococcus CKU-172003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID320961Inhibition of serotonin release in bovine platelets2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Neural networks as valuable tools to differentiate between sesquiterpene lactones' inhibitory activity on serotonin release and on NF-kappaB.
AID356405Antibacterial activity against methicillin-resistant Staphylococcus aureus2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID356398Cytotoxicity against human OVCAR-3 cells after 48 hrs by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID356397Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID356407Antibacterial activity against Escherichia coli2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID336310Antimigraine activity in bovine citreated platelet assessed as inhibition of [14C]serotonin release after 6 mins by scintillation counting1992Journal of natural products, Aug, Volume: 55, Issue:8
A bioassay for inhibition of serotonin release from bovine platelets.
AID356399Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID356406Antibacterial activity against Enterococcus faecalis2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID1101793Induction of Orobanche cernua var. cumana seed germination at 10 uM after 6 days2002Journal of agricultural and food chemistry, Mar-27, Volume: 50, Issue:7
SAR studies of sesquiterpene lactones as Orobanche cumana seed germination stimulants.
AID356402Antibacterial activity against Staphylococcus aureus2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's3 (15.79)18.2507
2000's5 (26.32)29.6817
2010's6 (31.58)24.3611
2020's4 (21.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.33 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]